BIONDVAX PHARMACEUTICALS LTD's ticker is BVXV and the CUSIP is 09073Q105. A total of 20 filers reported holding BIONDVAX PHARMACEUTICALS LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $200,000 | +14.3% | 85,181 | +7.2% | 0.00% | – |
| Q3 2021 | $175,000 | -23.9% | 79,440 | -0.8% | 0.00% | – |
| Q2 2021 | $230,000 | -22.3% | 80,091 | +2.8% | 0.00% | – |
| Q1 2021 | $296,000 | +48.0% | 77,911 | +9.6% | 0.00% | – |
| Q4 2020 | $200,000 | -69.0% | 71,111 | +331.3% | 0.00% | – |
| Q3 2020 | $645,000 | – | 16,489 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRUE Private Wealth Advisors | 55,500 | $64,000 | 0.01% |
| Aspire Private Capital, LLC | 1,600 | $2,000 | 0.00% |
| ROYAL BANK OF CANADA | 2,540 | $3,000 | 0.00% |
| UBS Group AG | 4,692 | $5,000 | 0.00% |
| CREDIT AGRICOLE S A | 4,240 | $5,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 200 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 13,768 | $16,000 | 0.00% |
| MORGAN STANLEY | 33,281 | $39,000 | 0.00% |
| Renaissance Technologies | 18,300 | $21,000 | 0.00% |